Supplemental material
Open access
1,505
Views
0
CrossRef citations to date
0
Altmetric
Original Research
A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea
Jae-Cheol Joa Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of KoreaView further author information
, Youngwoo Jeonb Department of Hematology, Lymphoma and Cell Therapy–Research Center, Yeouido St. Mary’s Hospital, The Catholic University of Korea, Seoul, Republic of Koreahttps://orcid.org/0000-0003-3362-8200View further author information
, DaJung Kimc Department of Internal Medicine, Kosin University College of Medicine, Kosin University, Seo-gu, Busan, Republic of Koreahttps://orcid.org/0000-0003-2375-8140View further author information
, Deok-Hwan Yangd Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun-gun, Jeollanam-do, Republic of KoreaView further author information
, Won Sik Leee Department of Internal Medicine, Hemato-oncology, Inje University Busan Paik Hospital, Busangjin-gu, Busan, Republic of Koreahttps://orcid.org/0000-0002-7956-468XView further author information
, Yoon Seok Choif Department of Hematology-Oncology, Ajou University Hospital, Suwon, Gyeonggi-do, Republic of KoreaView further author information
, Jun Ho Yig Department of Internal Medicine, Division of Hematology and Oncology, Chung-ang University Hospital, Dongjak-gu, Seoul, Republic of Koreahttps://orcid.org/0000-0003-1499-7131View further author information
, Dok Hyun Yoonh Department of Oncology, Asan Medical Center, Songpa-gu, Seoul, Republic of KoreaView further author information
, Jee Hyun Kongi Department of Hematology-Oncology, Division of Internal Medicine, Wonju Severance Christian Hospital, Wonju, Gangwon-do, Republic of KoreaView further author information
, Jung-Yoon Choej Department of Internal Medicine, Daegu Catholic University School of Medicine, Nam-gu, Daegu, Republic of KoreaView further author information
, SungHyun Kimk Celltrion, Inc., Yeonsu-gu, Incheon, Republic of KoreaView further author information
, KeumYoung Ahnk Celltrion, Inc., Yeonsu-gu, Incheon, Republic of Koreahttps://orcid.org/0000-0002-9370-5338View further author information
, TaeHong Parkk Celltrion, Inc., Yeonsu-gu, Incheon, Republic of Koreahttps://orcid.org/0000-0003-1922-2810View further author information
, Hana Juk Celltrion, Inc., Yeonsu-gu, Incheon, Republic of Koreahttps://orcid.org/0000-0002-9504-9995View further author information
, Soonbum Kwonk Celltrion, Inc., Yeonsu-gu, Incheon, Republic of Koreahttps://orcid.org/0000-0002-0517-8647View further author information
& Seok-Goo Chol Department of Hematology, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seocho-gu, Seoul, Republic of KoreaCorrespondence[email protected]
https://orcid.org/0000-0002-5429-4839View further author information
show allhttps://orcid.org/0000-0002-5429-4839View further author information
Pages 737-747
|
Received 13 Sep 2022, Accepted 02 Feb 2023, Published online: 08 Mar 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.